C.R. Bard (NYSE:BCR) revealed a 1-2 punch today when it reported another loss in its patent infringement war with W.L. Gore & Assoc. and an adverse insurance decision that could cost it $25 million.
Endoscopic
Kips Bay rises on FDA trial approval, despite losses in sales and revenue
Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.
Israeli acid reflux treatment group closes $8M private placement
Israel-based medical device maker Medigus Ltd. closed a $8 million private placement in support of its SRS Endoscopic system, a minimally invasive treatment for gastroesophageal reflux disease.
The round was sold to OrbiMed Israel Partners Limited Partnership which received 39.9 million shares of Medigus, representing 30.7% of the company.
Stanford engineers touts thin-as-hair endoscope
Stanford researchers developed a working prototype of an endoscope as thin as a human hair that they say "would be the ultimate minimally invasive imaging system."
The so-called "micro-endoscope" can produce images at a resolution 4 times higher than similar devices, and it could have important applications in healthcare.
FDA slaps Lumenis recall with Class I status
The FDA slapped the recall of the Lumenis VersaCut tissue morcellator with Class I status, denoting a device that can cause serious injury or death.
Morcellators are used to cut and remove large masses of tissue during laparoscopic procedures. Yokneam, Israel-based Lumenis is pulling the devices due to a labeling problem that could lead to "serious adverse health consequences, including death," according to the FDA.
FDA approves Lombard Med. Tech.’s Aorfix stent graft for treating highest neck angulation
British medical device maker Lombard Medical Technologies (LON:LMT) won premarket approval from the FDA to market its Aorfix flexible stent graft in the U.S.
HealthTrust strikes deals with Teleflex, Ivera Medical
Novation cuts new deals with medical device giants
Legal: W.L. Gore wins bid to re-examine Bard’s stent-graft patents
Gore wins CE Mark for lower-profile stent-graft components
Arizona medical device maker W.L. Gore & Assoc. announced CE Mark approval in the European Union for new components of its Gore Excluder AAA endoprosthesis in treatment of abdominal aortic aneurysms.
European regulators cleared Gore’s lower-profile 31 mm diameter ipsilateral leg and 32 mm aortic extender, designed for use with the Excluder AAA stent-graft in sealing off aneurysms and creating new paths for blood flow.
Supreme Court denies W.L. Gore in stent graft patent spat with C.R. Bard
The U.S. Supreme Court dashed the last hopes of W.L. Gore & Assoc. in its long-running patent war with C.R. Bard (NYSE:BCR) over vascular graft technology.